medigraphic.com

2017, Number 4

<< Back

Rev Med Inst Mex Seguro Soc 2017; 55 (4)

Overlap syndrome. LEOPARD and neurofi bromatosis. A case report

Revollo-Guerra IM, Vázquez-Román R

Language: Spanish
References: 16
Page: 540-543
PDF size: 108.37 Kb.


ABSTRACT

We expose a clinical case of a 43-year-old patient who was attended at the Dermatology service in a general hospital of the Instituto Mexicano del Seguro Social, with a disseminated pattern of lentigines, psychomotor retardation and electrocardiographic abnormalities. Afterwards, we made an analysis of the literature.


REFERENCES

  1. Aldama O, Domínguez L, Rivelli V. Síndrome de LEOPARD (Lentiginosis progresiva cardiomiopática). Dermatología Pediátrica de Paraguay. 2009;7(2).

  2. Fernández-Bussy R, Larraza M, Bernardini MC. Manifestaciones cutáneas de enfermedades sistémicas. Revista Médica de Rosario Argentina. 2013; 79:78-89.

  3. Sarkozy A, Conti E, Digilio MC, Marino B, Morini E, Pacileo G, et al. Clinical and molecular analysis of 30 patients with multiple lentigines LEOPARD Syndrome. J Med Genet. 2004 May;41(5):e68.

  4. Rodríguez-Cruz R, López LM, Valle-Molina L. Síndrome de LEOPARD asociado a estenosis pulmonar. Revista Hospital Juárez México. 2011;78(3):11.

  5. Galván-Moreira O, Salmentón G. Síndrome de lentiginosis múltiple. Revista Pediátrica Uruguaya. 2004; 75(4)316-9.

  6. Won-Woo C, Jong-Yeop Y, Kyoung-Chan P, Kyu-Han K. LEOPARD Syndrome with a new association of congenital corneal tumor, choristoma. Pediatric Dermatology. 2003;20(2):158-60.

  7. Garg S, Green J, Leadbitter K, Emsley R, Lehtonen A, Evans DG, et al. Neurofi bromatosis Type 1 and Autism Spectrum Disorder. Pediatrics. 2013 Dec; 132(6):e1642-8.

  8. Darrigo LG, Geller M, Bonalumi-Filho A. Prevalence of plexiform neurofi broma in children and adolescents with type I neurofi bromatosis. J Pediatr. 2007; 83(6):571-3.

  9. Camini L, Scheibe A, Masiero N, Cesteri T. ¿Qué síndrome es? Dermatology. 2006;4(2).

  10. Carcavilla A, Santomé J, Pinto I. Síndrome de LEOPARD: una variedad del Síndrome de Noonan con fuerte asociación a miocardiopatía hipertrófi ca. Rev Esp Cardiol. 2013;66:350-6.

  11. Rodríguez-Bujaldón A. LEOPARD Syndrome: What are café noir spots? Pediatric Dermatology. 2008;25 (4):444-8.

  12. Lehmann LH, Schaeufele T, Buss SJ, Balanova M, Hartschuh W, Ehlermann P, et al. A patient with LEOPARD syndrome and PTPN11 mutation. Circulation. 2009 Mar 10;119(9):1328-9.

  13. Scacchi MF, Boldrini P, Boggio P. Síndrome de LEOPARD: comunicación de cuatro casos familiares y revisión de la literatura. Dermatology Pediatric Lat. 2011;9(2).

  14. Laux D, Kratz C, Sauerbrey A. Common Acute Lymphoblastic Leukemia in a girl with genetically confi rmed LEOPARD Syndrome. J Pediatr Hematol Oncol. 2008 Aug;30(8):602-4.

  15. Ucar C, Calypkan U, Martini S, Heinritz W. Acute myelomonocytic leukemia in boy with LEOPARD Syndrome (PTPN11 Gene mutation positive). Journal of Pediatric Hematology/Oncology. March 2006; 28(3):123-5.

  16. Keren B, Hadchouel A, Saba S, Sznajer Y, Bonneau D, Leheup B, et al. PTPN11 mutations in patients with LEOPARD syndrome: a French multicentric experience. J Med Genet. 2004 Nov;41(11):e117.




2020     |     www.medigraphic.com